Docart SRL
1.3 FTEThe score of Docart shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +138 % Total assets +42 % Headcount (avg FTE) +30 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Docart's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 312,073 € | ||||
| Net result | 68,277 € | ||||
| Equity | 413,524 € | ||||
| Cash | 266,866 € | ||||
| EBITDA | 134,628 € | ||||
| Total assets | 456,558 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Jun 2026
- Year ended 31 Dec 2024filed on 31 Oct 2025
- Year ended 31 Dec 2023filed on 16 Jul 2024
- Year ended 31 Dec 2022filed on 23 Oct 2023
- Year ended 31 Dec 2021filed on 31 Oct 2022
Docart's financial analysis
- Solvency90.6%sector median: 72.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Docart
Docart's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0752.956.362
- VAT number
- BE0752956362
- Peppol
- Registered · 0208:0752956362 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Aug 2020
- Registered office
- 2280 Grobbendonk
- Size
- Micro · 1.3 FTE
- Latest accounts
- 2025 · filed on 25 Jun 2026
- Activity
- General medical practice activities (NACE 86210)
Docart (SRL) has been based in Grobbendonk since 2020, active in: general medical practice activities. For 2025, it reports revenue of 312,073 €, a net profit of 68,277 € and equity of 413,524 €. With 1.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 90.6%, above the median of its sector (72.4%).
Companies similar to Docart
Companies in the same business, of comparable size and area, outside its group.
- Dokter ANNE GEYSKENS General medical practice activities Lille · balance sheet 457,199 €
- DR. Paul Vanhoof, Huisarts General medical practice activities Olen · balance sheet 458,005 €
- Docteur JASPART Estelle General medical practice activities Ottignies-Louvain-la-Neuve · balance sheet 456,632 €
- Medicalelong General medical practice activities Mons · balance sheet 456,813 €
- Cabinet Medical Docteur Kmeid General medical practice activities Blegny · balance sheet 456,833 €
- Dr. Sengeleng Jan General medical practice activities Hamme (Vl.) · balance sheet 457,498 €
- Huisartspraktijk DE Molen General medical practice activities Houthalen-Helchteren · balance sheet 457,696 €
- DR. L. Bessems General medical practice activities Zemst · balance sheet 458,244 €
Frequently asked questions about Docart
What is the revenue of Docart?
According to the 2025 annual accounts filed with the NBB, the revenue of Docart amounts to 312,073 €.
What is the VAT number of Docart?
In Belgium, the VAT number is the company number prefixed with BE: BE0752956362 for Docart, if the company is VAT-registered. Its company number (CBE) is 0752.956.362.
Where is the registered office of Docart?
According to the CBE register, the registered office of Docart is in 2280 Grobbendonk.
What is the equity of Docart?
At the close of the 2025 financial year, the equity of Docart amounts to 413,524 €, a solvency of 90.6% of total assets.
How many people work at Docart?
1.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Docart?
The register lists 1 active mandates at Docart. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Docart
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →